BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 16, 2010
View Archived Issues
4-PBA and curcumin enhance protein expression of mutant ATP7B / News in Context
Read More
Genzyme reports 2-year data from phase II Gaucher's disease trial
Read More
Bristol-Myers Squibb reports results from fourth quarter 2009, ended December 31
Read More
Shionogi files additional application in Japan for pediatric use of Rapiacta
Read More
Oxigene presents update on development of Zybrestat
Read More
3SBio submits application in China for phase I clinical trial of NuPIAO
Read More
Debiopharm's Clinical Trial Application for Debio-0932 approved in France
Read More
Helix reports preliminary results from phase II study of topical interferon alpha-2b
Read More
ADX-71943 demonstrates analgesic effects in preclinical pain models
Read More
Repros submits response to FDA regarding Androxal in hypogonadism
Read More
LJ-001, a broad-spectrum antiviral targeting the viral lipid membrane
Read More
Solvay claims novel adenosine A1 receptor antagonists
Read More
Amakem starts operations to discover and develop novel kinase inhibitors
Read More
Bristol-Myers Squibb claims MAP kinase inhibitors for inflammatory disorders
Read More
Millennium Pharmaceuticals patents novel proteasome inhibitors
Read More
Older vaccines provide protection against 2009 pandemic H1N1 influenza
Read More
Genentech identifies new Janus kinase inhibitors
Read More
Roche claims monoamine reuptake inhibitors for the treatment of affective disorders
Read More
HDAC inhibitor SAHA restores activity of mutant CFTR in vitro
Read More
Fingolimod shows clinical benefit in two phase III trials in relapsing-remitting MS
Read More
AVI BioPharma receives grants for Duchenne muscular dystrophy drug development
Read More
Toyama initiates U.S. phase II trial for its anti-influenza drug candidate, T-705
Read More
Abbott acquires Solvay Pharmaceuticals for EUR 4.5 billion
Read More
AstraZeneca and Rigel sign license agreement for fostamatinib disodium in RA
Read More
Pharmaxis completes phase I clinical trial of PXS-25 in healthy volunteers
Read More